LOS ANGELES (Reuters) – Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial. The mid-stage study, conducted at the University of Texas M.D. Anderson Cancer Center in Houston and […]

Read More